01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.
Vumerity, INN-diroximel fumarate EPAR 2026
Here's how it works
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send it via email, link, or fax. You can also download it, export it or print it out.
How to use or fill out Vumerity, INN-diroximel fumarate EPAR with our platform
Ease of Setup
DocHub User Ratings on G2
Ease of Use
DocHub User Ratings on G2
- Click ‘Get Form’ to open the Vumerity EPAR document in the editor.
- Begin by reviewing the 'Name of the Medicinal Product' section. Ensure that it states 'Vumerity 231 mg gastro-resistant hard capsules' clearly.
- Proceed to the 'Qualitative and Quantitative Composition' section. Here, confirm that each capsule contains 231 mg of diroximel fumarate as listed.
- In the 'Pharmaceutical Form' section, verify that it describes the product accurately as a gastro-resistant hard capsule.
- Move on to 'Clinical Particulars'. This section outlines therapeutic indications and posology. Make sure to note that treatment should be initiated under physician supervision.
- Fill out any relevant fields regarding contraindications and special warnings. Highlight important information such as risks associated with PML and lymphopenia.
- Review the 'Undesirable Effects' section for any potential side effects that may need attention during treatment.
Start using our platform today to streamline your document editing and ensure accurate completion of your Vumerity EPAR!
See more Vumerity, INN-diroximel fumarate EPAR versions
We've got more versions of the Vumerity, INN-diroximel fumarate EPAR form. Select the right Vumerity, INN-diroximel fumarate EPAR version from the list and start editing it straight away!
| Versions | Form popularity | Fillable & printable |
|---|---|---|
| 2022 | 4.8 Satisfied (36 Votes) |
Is Vumerity a good MS medication?
Most medicines for treating MS require an injection; however, newer oral medicines, like Vumerity, provide an easier treatment option. Oral options can be more convenient, but they may not be better or worse than other types of MS treatments.
How much does Vumerity cost a year?
In a statement following the approval, Biogen said weve made the decision to launch Vumerity in the US with the lowest annual WAC price for oral MS disease-modifying therapies at an annualised price of $88,000.
Is Vumerity a chemo drug?
Vumerity has anti-inflammatory and antioxidant properties. It contains the active ingredient diroximel fumarate and comes as a delayed-release oral capsule. Vumerity is not a chemotherapy or immunosuppressant drug.
What is the drug Vumerity used for?
Vumerity is a medicine used to treat adults with a type of multiple sclerosis (MS) known as relapsing-remitting MS.
Security and compliance
At DocHub, your data security is our priority. We follow HIPAA, SOC2, GDPR, and other standards, so you can work on your documents with confidence.
